According to the Act shareholder platform, a July 8 survey of EcoPro BM shareholders revealed an unexpected shift in sentiment toward the company's 1.2 trillion won capital increase. Among 69 participating shareholders, 43 shareholders holding 18,419 shares voted against requesting a regulatory review, compared to 25 shareholders holding 9,682 shares voting in favor—a stark reversal from anticipated resistance to equity dilution.
The low participation rate stood in sharp contrast to historical precedent. When Hanwha Q CELLS announced a similar fundraising in March 2026, over 1,800 shareholders participated in the Act platform discussion, with 154 shareholders holding 523,317 shares supporting a change in the fundraising method in just 17 hours. The company's latest fundraising announcement on June 30 triggered a 20 percent intraday stock decline.